Clinical Trial Update: Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing pharmacokinetics and safety/tolerability after oral dosing of two investigational compounds, CKD-387 and D635, in healthy adults for pot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-387
• D635

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN